<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000666707"><TermName>anti-HGF monoclonal antibody AMG 102</TermName><TermPronunciation>(AN-tee … MAH-noh-KLOH-nul AN-tee-BAH-dee ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It binds to a protein called hepatocyte growth factor (HGF), which may cause cancer cells to grow.  Blocking this may cause cancer cells to die. Anti-HGF monoclonal antibody AMG 102 is a type of monoclonal antibody. Also called AMG 102.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726034" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anti-HGF monoclonal antibody AMG 102&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726035" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anticuerpo monoclonal AMG 102 anti-FCH&quot;" language="es" id="_4"/><SpanishTermName>anticuerpo monoclonal AMG 102 anti-FCH</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Se une a una proteína que se llama factor de crecimiento hepatocítico (FCH), que puede hacer crecer las células cancerosas. El bloqueo de   esta sustancia puede hacer que las células cancerosas se destruyan. El anticuerpo monoclonal AMG 102 anti-FCH es un tipo de anticuerpo monoclonal. También se llama AMG 102.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-06-08</DateFirstPublished></GlossaryTerm>
